Efficient production of Hantaan and Puumala pseudovirions for viral tropism and neutralization studies

Virology

Volumn 423, Issue 2, 2012, Pages 134-142

  Higa, Meda M ^a   Petersen, Josiah ^a   Hooper, Jay ^b   Doms, Robert W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Bunyaviridae; Glycoprotein; Hantaan; Hantavirus; Pseudovirions; Puumala; Virus entry

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS RNA; VITRONECTIN RECEPTOR;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CELL PH; CONTROLLED STUDY; HANTAVIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PSEUDOVIRION; PUUMALA VIRUS; QUANTITATIVE ANALYSIS; STABLE EXPRESSION; T LYMPHOCYTE; VESICULAR STOMATITIS VIRUS; VIRAL PHENOMENA AND FUNCTIONS; VIRAL TROPISM; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS CORE; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; HANTAAN VIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; MICE; NEUTRALIZATION TESTS; PUUMALA VIRUS; VIRAL TROPISM; VIRUS CULTIVATION;

BUNYAVIRIDAE; HANTAAN VIRUS; HANTAVIRUS; PUUMALA; VESICULAR STOMATITIS VIRUS;

EID: 84855758593     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.08.012     Document Type: Article

References (54)

1. Allison S.L., Schalich J., Stiasny K., Mandl C.W., Kunz C., Heinz F.X. Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J. Virol. 1995, 69(2):695-700.
2. Battisti A.J., Chu Y.K., Chipman P.R., Kaufmann B., Jonsson C.B., Rossmann M.G. Structural studies of Hantaan virus. J. Virol. 2011, 85(2):835-841.
3. Cifuentes-Munoz N., Darlix J.L., Tischler N.D. Development of a lentiviral vector system to study the role of the Andes virus glycoproteins. Virus Res. 2010, 153(1):29-35.
4. Cifuentes-Munoz N., Barriga G.P., Valenzuela P.D., Tischler N.D. Aromatic and polar residues spanning the candidate fusion peptide of the Andes virus Gc protein are essential for membrane fusion and infection. J. Gen. Virol. 2011, 92(Pt 3):552-563.
5. Coleman J.W., Ogin-Wilson E., Johnson J.E., Nasar F., Zamb T.P., Clarke D.K., Hendry R.M., Udem S.A. Quantitative multiplex assay for simultaneous detection of the Indiana serotype of vesicular stomatitis virus and HIV gag. J. Virol. Methods 2007, 143(1):55-64.
6. Custer D.M., Thompson E., Schmaljohn C.S., Ksiazek T.G., Hooper J.W. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J. Virol. 2003, 77(18):9894-9905.
7. Deyde V.M., Rizvanov A.A., Chase J., Otteson E.W., St Jeor S.C. Interactions and trafficking of Andes and Sin Nombre Hantavirus glycoproteins G1 and G2. Virology 2005, 331(2):307-315.
8. Doms R.W., Keller D.S., Helenius A., Balch W.E. Role for adenosine triphosphate in regulating the assembly and transport of vesicular stomatitis virus G protein trimers. J. Cell Biol. 1987, 105(5):1957-1969.
9. Earp L.J., Delos S.E., Park H.E., White J.M. The many mechanisms of viral membrane fusion proteins. Curr. Top. Microbiol. Immunol. 2005, 285:25-66.
10. Garry C.E., Garry R.F. Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes). Theor. Biol. Med. Model. 2004, 1:10.
11. Gavrilovskaya I.N., Shepley M., Shaw R., Ginsberg M.H., Mackow E.R. beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(12):7074-7079.
12. Gavrilovskaya I.N., Brown E.J., Ginsberg M.H., Mackow E.R. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J. Virol. 1999, 73(5):3951-3959.
13. Hammerbeck C.D.a.H., Jay W. Hantavirus vaccines. New Generation Vaccines 2010, 905-913. Informa Healthcare, New York. Fourth Edition ed. M.M. Levine (Ed.).
14. Hepojoki J., Strandin T., Vaheri A., Lankinen H. Interactions and oligomerization of hantavirus glycoproteins. J. Virol. 2010, 84(1):227-242.
15. Hooper, J. (manuscript in preparation).
16. Hooper J.W., Kamrud K.I., Elgh F., Custer D., Schmaljohn C.S. DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against Seoul virus infection. Virology 1999, 255(2):269-278.
17. Hooper J.W., Custer D.M., Thompson E., Schmaljohn C.S. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys. J. Virol. 2001, 75(18):8469-8477.
18. Hooper J.W., Custer D.M., Smith J., Wahl-Jensen V. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates. Virology 2006, 347(1):208-216.
19. Hooper J.W., Ferro A.M., Wahl-Jensen V. Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus. J. Virol. 2008, 82(3):1332-1338.
20. Huggins J.W., Hsiang C.M., Cosgriff T.M., Guang M.Y., Smith J.I., Wu Z.O., LeDuc J.W., Zheng Z.M., Meegan J.M., Wang Q.N., et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J. Infect. Dis. 1991, 164(6):1119-1127.
21. Huiskonen J.T., Hepojoki J., Laurinmaki P., Vaheri A., Lankinen H., Butcher S.J., Grunewald K. Electron cryotomography of Tula hantavirus suggests a unique assembly paradigm for enveloped viruses. J. Virol. 2010, 84(10):4889-4897.
22. Hung T., Zhou J.Y., Tang Y.M., Zhao T.X., Baek L.J., Lee H.W. Identification of Hantaan virus-related structures in kidneys of cadavers with haemorrhagic fever with renal syndrome. Arch. Virol. 1992, 122(1-2):187-199.
23. Jin M., Park J., Lee S., Park B., Shin J., Song K.J., Ahn T.I., Hwang S.Y., Ahn B.Y., Ahn K. Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology 2002, 294(1):60-69.
24. Jonsson C.B., Hooper J., Mertz G. Treatment of hantavirus pulmonary syndrome. Antiviral Res. 2008, 78(1):162-169.
25. Kielian M. Class II virus membrane fusion proteins. Virology 2006, 344(1):38-47.
26. Krautkramer E., Zeier M. Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55). J. Virol. 2008, 82(9):4257-4264.
27. Lefrancois L., Lyles D.S. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology 1982, 121(1):157-167.
28. Lober C., Anheier B., Lindow S., Klenk H.D., Feldmann H. The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. Virology 2001, 289(2):224-229.
29. Maes P., Clement J., Van Ranst M. Recent approaches in hantavirus vaccine development. Expert Rev. Vaccines 2009, 8(1):67-76.
30. Matthys V.S., Gorbunova E.E., Gavrilovskaya I.N., Mackow E.R. Andes virus recognition of human and Syrian hamster beta3 integrins is determined by an L33P substitution in the PSI domain. J. Virol. 2010, 84(1):352-360.
31. McCaughey C., Shi X., Elliot R.M., Wyatt D.E., O'Neill H.J., Coyle P.V. Low pH-induced cytopathic effect-a survey of seven hantavirus strains. J. Virol. Methods 1999, 81(1-2):193-197.
32. Mertz G.J., Miedzinski L., Goade D., Pavia A.T., Hjelle B., Hansbarger C.O., Levy H., Koster F.T., Baum K., Lindemulder A., Wang W., Riser L., Fernandez H., Whitley R.J. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin. Infect. Dis. 2004, 39(9):1307-1313.
33. Moll M., Kaufmann A., Maisner A. Influence of N-glycans on processing and biological activity of the Nipah virus fusion protein. J. Virol. 2004, 78(13):7274-7278.
34. Mou D.L., Wang Y.P., Huang C.X., Li G.Y., Pan L., Yang W.S., Bai X.F. Cellular entry of Hantaan virus A9 strain: specific interactions with beta3 integrins and a novel 70kDa protein. Biochem. Biophys. Res. Commun. 2006, 339(2):611-617.
35. Negrete O.A., Levroney E.L., Aguilar H.C., Bertolotti-Ciarlet A., Nazarian R., Tajyar S., Lee B. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 2005, 436(7049):401-405.
36. Netski D., Thran B.H., St Jeor S.C. Sin Nombre virus pathogenesis in Peromyscus maniculatus. J. Virol. 1999, 73(1):585-591.
37. Ogino M., Ebihara H., Lee B.H., Araki K., Lundkvist A., Kawaoka Y., Yoshimatsu K., Arikawa J. Use of vesicular stomatitis virus pseudotypes bearing Hantaan or Seoul virus envelope proteins in a rapid and safe neutralization test. Clin. Diagn. Lab. Immunol. 2003, 10(1):154-160.
38. Ogino M., Yoshimatsu K., Ebihara H., Araki K., Lee B.H., Okumura M., Arikawa J. Cell fusion activities of Hantaan virus envelope glycoproteins. J. Virol. 2004, 78(19):10776-10782.
39. Overby A.K., Pettersson R.F., Grunewald K., Huiskonen J.T. Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(7):2375-2379.
40. Pekosz A., Gonzalez-Scarano F. The extracellular domain of La Crosse virus G1 forms oligomers and undergoes pH-dependent conformational changes. Virology 1996, 225(1):243-247.
41. Puri A., Winick J., Lowy R.J., Covell D., Eidelman O., Walter A., Blumenthal R. Activation of vesicular stomatitis virus fusion with cells by pretreatment at low pH. J. Biol. Chem. 1988, 263(10):4749-4753.
42. Ray N., Whidby J., Stewart S., Hooper J.W., Bertolotti-Ciarlet A. Study of Andes virus entry and neutralization using a pseudovirion system. J. Virol. Methods 2010, 163(2):416-423.
43. Raymond T., Gorbunova E., Gavrilovskaya I.N., Mackow E.R. Pathogenic hantaviruses bind plexin-semaphorin-integrin domains present at the apex of inactive, bent alphavbeta3 integrin conformers. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(4):1163-1168.
44. Robison C.S., Whitt M.A. The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly. J. Virol. 2000, 74(5):2239-2246.
45. Rolls M.M., Webster P., Balba N.H., Rose J.K. Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell 1994, 79(3):497-506.
46. Shi X., Elliott R.M. Golgi localization of Hantaan virus glycoproteins requires coexpression of G1 and G2. Virology 2002, 300(1):31-38.
47. Takada A., Robison C., Goto H., Sanchez A., Murti K.G., Whitt M.A., Kawaoka Y. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 1997, 94(26):14764-14769.
48. Tamin A., Harcourt B.H., Ksiazek T.G., Rollin P.E., Bellini W.J., Rota P.A. Functional properties of the fusion and attachment glycoproteins of Nipah virus. Virology 2002, 296(1):190-200.
49. Tischler N.D., Gonzalez A., Perez-Acle T., Rosemblatt M., Valenzuela P.D. Hantavirus Gc glycoprotein: evidence for a class II fusion protein. J. Gen. Virol. 2005, 86(Pt 11):2937-2947.
50. Tsai T.F. Hemorrhagic fever with renal syndrome: mode of transmission to humans. Lab. Anim. Sci. 1987, 37(4):428-430.
51. Ulrich R., Hjelle B., Pitra C., Kruger D.H. Emerging viruses: the case 'hantavirus'. Intervirology 2002, 45(4-6):318-327.
52. Yu I.M., Zhang W., Holdaway H.A., Li L., Kostyuchenko V.A., Chipman P.R., Kuhn R.J., Rossmann M.G., Chen J. Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 2008, 319(5871):1834-1837.
53. Zaki S.R., Greer P.W., Coffield L.M., Goldsmith C.S., Nolte K.B., Foucar K., Feddersen R.M., Zumwalt R.E., Miller G.L., Khan A.S., et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol. 1995, 146(3):552-579.
54. Zheng F., Ma L., Shao L., Wang G., Chen F., Zhang Y., Yang S. Envelope glycoproteins of hantavirus can mediate cell-cell fusion independently. New Microbiol. 2007, 30(2):101-107.